Sánchez-Guerrero I, Albaladejo M D, García-Alonso A M, Muro M, Hernández J, Alvarez M R
Sección de Inmunología, Hospital Universitario Virgen de la Arrixaca, Murcia, Spain.
Allergy. 1994 Sep;49(8):587-92. doi: 10.1111/j.1398-9995.1994.tb00123.x.
To determine serum levels of IgE and sCD23 and lymphocyte subpopulations, we studied 37 control subjects and 84 patients (27 with allergic rhinitis, 27 with extrinsic asthma, and 30 with intrinsic asthma). A rise in surface CD23 on B and monocyte cells and sCD23 serum levels was exhibited by patients with rhinitis and extrinsic asthma. Unexpectedly, in intrinsic asthmatic patients, high CD23 expression on monocytes and high sCD23 levels were seen that did not result in IgE production. It appears that CD23, in its soluble form, could be a good disease marker, especially in asthma. Atopic patients yielded a significantly lower proportion of CD4+ T cells than intrinsic asthmatic patients and normal persons. Otherwise, CD4+CD29+CD45RA- and CD4+CD29-CD45RA T-cell subsets were significantly decreased in all patient groups.
为了测定血清IgE、可溶性CD23(sCD23)水平及淋巴细胞亚群,我们研究了37名对照受试者和84例患者(27例变应性鼻炎、27例过敏性哮喘和30例非过敏性哮喘)。鼻炎和过敏性哮喘患者的B细胞和单核细胞表面CD23及血清sCD23水平升高。出乎意料的是,在非过敏性哮喘患者中,单核细胞上CD23高表达且sCD23水平升高,但未导致IgE产生。看来,可溶性形式的CD23可能是一种良好的疾病标志物,尤其是在哮喘中。特应性患者的CD4+T细胞比例明显低于非过敏性哮喘患者和正常人。此外,所有患者组中CD4+CD29+CD45RA-和CD4+CD29-CD45RA T细胞亚群均显著减少。